Table 4.

Incidences of adverse events reported by >10% of patientsa

ParameterPatients Who Experienced at Least One AE
MMF (n = 184)IVC (n = 180)
Deaths9 (4.9)5 (2.8)
Withdrawals as a result of AEs24 (13.0)13 (7.2)
All AEs177 (96.2)171 (95.0)
    diarrhea52 (28.3)23 (12.8)
    headache38 (20.7)47 (26.1)
    peripheral edema35 (19.0)30 (16.7)
    arthralgia29 (15.8)43 (23.9)
    nausea27 (14.7)82 (45.6)
    hypertension26 (14.1)25 (13.9)
    nasopharyngitis25 (13.6)29 (16.1)
    vomiting25 (13.6)68 (37.8)
    cough24 (13.0)16 (8.9)
    anemia23 (12.5)12 (6.7)
    alopecia20 (10.9)64 (35.6)
    abdominal pain19 (10.3)13 (7.2)
    back pain19 (10.3)16 (8.9)
    muscle spasms19 (10.3)17 (9.4)
    rash19 (10.3)21 (11.7)
    urinary tract infection19 (10.3)17 (9.4)